EPIZYME, INC.
Patent Owner
Stats
- 79 US PATENTS IN FORCE
- 33 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 79 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,166 Total Citation Count
- Sep 12, 2011 Earliest Filing
- 11 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0298,073 SALTS, CO-CRYSTALS, AMORPHOUS FORMS, AND CRYSTALLINE FORMS OF A CO-ACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) INHIBITORSep 17, 15Oct 19, 17[C07D, C07C]
2017/0280,720 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOFSep 17, 15Oct 05, 17[A01N, C07D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9776972 Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofMar 14, 14Oct 03, 17[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0065,600 INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOFAbandonedApr 19, 16Mar 09, 17[A61K, G01N]
2016/0251,390 7-DEAZAPURINE MODULATORS OF HISTONE METHYLTRANSFERASE, AND METHODS OF USE THEREOFAbandonedSep 28, 15Sep 01, 16[C07H]
2016/0068,559 Modulators of Histone Methyltransferase, and Methods of Use ThereofAbandonedApr 07, 15Mar 10, 16[C07H]
2016/0039,767 PYRAZOLE DERIVATIVES AS PRMT1 INHIBITORS AND USES THEREOFAbandonedMar 14, 14Feb 11, 16[C07D]
2016/0031,839 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOFAbandonedMar 14, 14Feb 04, 16[C07D]
2015/0284,422 INHIBITORS OF PROTEIN METHYLTRANSFERASE DOT1L AND METHODS OF USE THEREOFAbandonedAug 12, 13Oct 08, 15[C07H, G06F, C40B]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.